Lomefloxacin versus ciprofloxacin in the treatment of chronic bacterial prostatitis

International Journal of Antimicrobial Agents

Volumn 20, Issue 1, 2002, Pages 18-27

  Naber, Kurt G ^a  

^a TECHNICAL UNIVERSITY OF MUNICH   (Germany)

Author keywords

Chronic bacterial prostatitis; Ciprofloxacin; Lomefloxacin

Indexed keywords

CIPROFLOXACIN; LOMEFLOXACIN; ANTIINFECTIVE AGENT; QUINOLONE DERIVATIVE;

ACINETOBACTER LWOFFII; ADULT; AGED; ARTICLE; CANDIDA GLABRATA; CARCINOMA; CHRONIC PROSTATITIS; CITROBACTER; CLINICAL TRIAL; COAGULASE NEGATIVE STAPHYLOCOCCUS; CONFIDENCE INTERVAL; CONTROLLED CLINICAL TRIAL; CONTROLLED STUDY; CYSTITIS; DEATH; DRUG EFFICACY; DRUG SAFETY; DYSURIA; ENTEROBACTER; ENTEROCOCCUS; ENTEROCOCCUS FAECALIS; ENUCLEATION; ESCHERICHIA COLI; GONORRHEA; GRAM NEGATIVE BACTERIUM; GRAM POSITIVE BACTERIUM; HAEMOPHILUS PARAINFLUENZAE; HEADACHE; HEMOSPERMIA; HUMAN; HYPERGLYCEMIA; KLEBSIELLA; MAJOR CLINICAL STUDY; MALE; MULTICENTER STUDY; NEISSERIA; PAIN; PRIORITY JOURNAL; PROTEUS MIRABILIS; PSEUDOMONAS AERUGINOSA; RANDOMIZED CONTROLLED TRIAL; RASH; RECURRENCE RISK; RELAPSE; SEMEN ABNORMALITY; SLEEP DISORDER; STAPHYLOCOCCUS; STAPHYLOCOCCUS AUREUS; STATISTICAL ANALYSIS; STREPTOCOCCUS AGALACTIAE; SUPERINFECTION; TREATMENT OUTCOME; UROGENITAL TRACT MALFORMATION; VERTIGO; VOMITING; XEROSTOMIA; CHRONIC DISEASE; DRUG EFFECT; MICROBIOLOGY; ORAL DRUG ADMINISTRATION; PROSTATITIS; PSEUDOMONAS; URINARY TRACT INFECTION;

ADMINISTRATION, ORAL; ADULT; ANTI-INFECTIVE AGENTS, FLUOROQUINOLONE; CHRONIC DISEASE; CIPROFLOXACIN; HUMAN; MALE; PROSTATITIS; PSEUDOMONAS; QUINOLONES; SUPPORT, NON-U.S. GOV'T; TREATMENT OUTCOME; URINARY TRACT INFECTIONS; ANTI-INFECTIVE AGENTS; FLUOROQUINOLONES; HUMANS;

EID: 0035996894     PISSN: 09248579     EISSN: None     Source Type: Journal    
DOI: 10.1016/S0924-8579(02)00067-5     Document Type: Article

References (26)

1. Treatment of chronic bacterial prostatitis with ciprofloxacin. Results of a one-year follow-up study
2. The efficacy of norfloxacin in the treatment of chronic bacterial prostatitis refractory to trimethoprim/sulfamethoxazole and/or carbenicillin
3. Ofloxacin in the management of complicated urinary tract infections, including prostatitis
4. Antibiotic treatment of chronic bacterial prostatitis
5. Pharmacokinetics and tolerance of lomefloxacin after sequentially increasing oral doses
6. Pharmacokinetics of lomefloxacin in reanlly compromised patients
7. Effect of food on absorption of lomefloxacin
8. Penetration of lomefloxacin into human prostatic tissue
9. Lomefloxacin penetration into prostatic and seminal fluid in volunteers
10. Lomefloxacin versus norfloxacin in the treatment of uncomplicated urinary tract infections: three-day versus seven-day treatment
11. A controlled trial of levofloxacin and lomefloxacin in the treatment of complicated urinary tract infection
12. The US clinical experience with lomefloxacin, a new once daily fluoroquinolone
13. Bacteriologic localization patterns in bacterial prostatitis and urethritis
14. Prediction of creatinine clearance from serum creatinine
15. Proposed study design in prostatitis,
16. StatXact software
17. Experience with the new guidelines on evaluation of new anti-infective drugs for the treatment of urinary tract infections
18. Evaluation of new anti-infective drugs for the treatment of urinary tract infection
19. General guidelines for the evaluation of new anti-infective drugs for the treatment of urinary tract infection
20. Ciprofloxacin in the treatment of chronic bacterial prostatitis: a prospective, non-comparative multicentre clinical trial with long-term follow-up
21. Refractory chronic bacterial prostatitis: a reevaluation of ciprofloxacin treatment after a median follow-up of 30 months
22. Estudo comparativo entre lomefloxacina e ofloxacina no tratamento da prostatite bacteriana cronica. (Clinical trial comparing lomefloxacin and ofloxacin in the treatment of chronic bacterial prostatitis)